Immune Network

Papers
(The TQCC of Immune Network is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Adenovirus Vectors: Excellent Tools for Vaccine Development61
Immune Checkpoint Inhibitors in 10 Years: Contribution of Basic Research and Clinical Application in Cancer Immunotherapy55
Targeted Immunotherapy for Autoimmune Disease51
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene50
Gut-Brain Connection: Microbiome, Gut Barrier, and Environmental Sensors44
SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues44
SARS-CoV-2 Infection of Airway Epithelial Cells42
Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages27
Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation23
Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic22
Toll-like Receptor 2 in Autoimmune Inflammation22
Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation18
The Role of Upper Airway Microbiome in the Development of Adult Asthma18
The Role of T Cells in Obesity-Associated Inflammation and Metabolic Disease16
Targeting the Epithelium-Derived Innate Cytokines: From Bench to Bedside15
Recent Advances in Allergen-Specific Immunotherapy in Humans: A Systematic Review14
Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 Vaccines13
CD11b Deficiency Exacerbates Methicillin-ResistantStaphylococcus aureus-Induced Sepsis by Upregulating Inflammatory Responses of Macrophages13
Immunopathology and Immunotherapy of Inflammatory Skin Diseases13
Transmission Characteristics of SARS-CoV-2 That Hinder Effective Control13
Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody12
Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy12
Experimental Animal Models of Coronavirus Infections: Strengths and Limitations12
Omicron Subvariants, Including BA.4 and BA.5, Substantially Preserve T Cell Epitopes of Ancestral SARS-CoV-212
SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals12
Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research11
CAR T Cell Immunotherapy Beyond Haematological Malignancy11
Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad10
Dietary Diversity during Early Infancy Increases Microbial Diversity and Prevents Egg Allergy in High-Risk Infants10
Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy10
Single Cell Transcriptomic Re-analysis of Immune Cells in Bronchoalveolar Lavage Fluids Reveals the Correlation of B Cell Characteristics and Disease Severity of Patients with SARS-CoV-2 Infection10
Human CD8+ T-Cell Populations That Express Natural Killer Receptors10
Recent Advances in Cell Therapeutics for Systemic Autoimmune Diseases9
Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis9
MiR-182-5p Mediated by Exosomes Derived From Bone Marrow Mesenchymal Stem Cell Attenuates Inflammatory Responses by Targeting TLR4 in a Mouse Model of Myocardial Infraction9
Gut Microbial Metabolites on Host Immune Responses in Health and Disease9
Mitofusin-2 Promotes the Epithelial-Mesenchymal Transition-Induced Cervical Cancer Progression9
NLRC4 Inflammasome-Mediated Regulation of Eosinophilic Functions8
Transcriptional and Epigenetic Regulation of Context-Dependent Plasticity in T-Helper Lineages8
Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier8
Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination8
Enriching CCL3 in the Tumor Microenvironment Facilitates T cell Responses and Improves the Efficacy of Anti-PD-1 Therapy8
0.032496929168701